Health Condition 1: J310- Chronic rhinitis Health Condition 2: J324- Chronic pansinusitis
Conditions
Interventions
Intervention1: ELUMICHAMPAZHA ILAGAM (Internal Medicine): Should be administered orally twice a day before food with Dosage 2.5gm-5gm according to the age of patients.Duration 48 days
Control Interven
Sponsors
Dr A KAVITHA
Eligibility
Inclusion criteria
Inclusion criteria: Recurrent upper respiratory tract infections The corrent required for study eligibility was defined by the presence of atleast two of the following Rhinitis Pharyngitis Cough,Sinusitis
Exclusion criteria
Exclusion criteria: Children below 3 years and above 12 years Genetic disease (SCID,CVID) Tuberculosis HIV,Cancer Lower Respiratory tract infections and Asthma
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This study will help to understanding the immunomodulatory activity of "ELUMICHAMPAZHA ILAGAM" and may contribute to improved healthcare outcomes in children by enhancing their immune response.Timepoint: The study outcomes, including symptomatic relief, reduction in recurrence, and improvement in quality of life, will be assessed at predefined time points at baseline (Day 0), during treatment (Day 28), and at the end of treatment (Day 48) to evaluate the efficacy of Elumichampazha ilagam for improving immunity in children | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr K SHYAMALA MD S
Government Siddha Medical College and Hospital Palayamkottai
Outcome results
None listed